Ho Wang Lee

In 1989 Lee and collaborators developed a formalin-inactivated suckling mouse Hantaan virus vaccine, which under the name Hantavax™ has been approved for commercial use in South Korea since 1990. In 1990 Tomiyama and Lee published their findings for their method of rapid serodiagnosis of hantavirus infections.

In 1976 Lee and his collaborators succeeded in isolating the virus causing Korean hemorrhagic fever; they gave it the name Hantaan virus (now called hantavirus or orthohantavirus). The discovery caused a sensation in the international community of medical researchers, because the quest for isolating the virus had been the subject of intense effort since the early 1950s. The research involved in isolating the virus was dangerous, and several of Lee's collaborators became ill due to aerosols produced by chronically infected rodents.

Ho Wang Lee (26 October 1928 – 5 July 2022) was a South Korean physician, epidemiologist, and virologist. He was the first person in the history of medicine to be the one chiefly responsible for all 3 of the following steps: (1) discovery of the virus causing a human disease, (2) development of a method of diagnosis for the disease, and (3) development of a vaccine against the disease.

Lee was born in Sinhung, South Hamgyong Province, Korea on 26 October 1928. He studied medicine at Seoul National University with an M.D. degree in 1954 and was awarded a doctorate at the University of Minnesota in 1959. From 1954 to 1972 he was a professor of microbiology at the Medical College of Seoul National University, as well as dean of the Medical College. From 1972 to 1994 he was the director of the Department of Virology of Korea University. From 1994 to his death he was the director of the ASAN Institute for Life Sciences in South Korea.